Showing results (51-60 of 71) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|July 29, 2015
Indole Glucocorticoid Receptor Antagonists Active in a Model of Dyslipidemia Act via a Unique Association with an Agonist Binding SiteJohn G Luz, Matthew W Carson, Bradley Condon, et al.Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Steven A Buckner, Michael J Coghlan, et al.Journal of Medicinal Chemistry|August 25, 2001
Synthesis and characterization of non-steroidal ligands for the glucocorticoid receptor: selective quinoline derivatives with prednisolone-equivalent functional activityM J Coghlan, P R Kym, S W Elmore, et al.Molecular Pharmacology|July 20, 2002
trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomersChun Wel Lin, Masaki Nakane, Mike Stashko, et al.Journal of Medicinal Chemistry|November 2, 2007
Structure-activity studies of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Michael E Brune, Steven A Buckner, et al.Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Structure-activity relationship of a novel class of naphthyl amide KATP channel openersSean C Turner, William A Carroll, Tammie K White, et al.Bioorganic & Medicinal Chemistry Letters|March 18, 2004
Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulatorsSteven W Elmore, John K Pratt, Michael J Coghlan, et al.British Journal of Pharmacology|February 15, 2019
Neprilysin inhibition for pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled, proof-of-concept trialAdrian J Hobbs, Amie J Moyes, Reshma S Baliga, et al.Molecular Endocrinology (Baltimore, Md.)|February 15, 2003
A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effectsMichael J Coghlan, Peer B Jacobson, Ben Lane, et al.Diabetes|September 9, 2010
Novel small molecule glucagon-like peptide-1 receptor agonist stimulates insulin secretion in rodents and from human isletsKyle W Sloop, Francis S Willard, Martin B Brenner, et al.Pageof 8